Die Suchmaschine für Unternehmensdaten in Europa

EU-Förderung (5.974.238 €): ERA-NET über Herz-Kreislauf-Erkrankungen zur Durchführung gemeinsamer transnationaler Forschungsprojekte und zur Gründung internationaler Kooperationen Hor 01.10.2015 EU-Rahmenprogramm für Forschung und Innovation "Horizont"

Auf einen Blick

Text

ERA-NET über Herz-Kreislauf-Erkrankungen zur Durchführung gemeinsamer transnationaler Forschungsprojekte und zur Gründung internationaler Kooperationen

Cardiovascular diseases (CVD) are the largest cause of death in the EU and account for around 2 million deaths per year. Overall, CVD are estimated to cause the economy of the EU costs of almost 196 billion Euros a year. Furthermore, they are one of the leading causes of long term sickness, chronic diseases and loss to the labour market. Therefore, CVD are a major health problem in Europe. Despite the overall burden of CVD on European citizens and national health systems, translational cardiovascular research is fragmented and mainly occurs at national levels. However, the present and future challenges in cardiovascular research can only be met by an effective cooperation at transnational level. Therefore, the proposed European Research Area Network on cardiovascular diseases (ERA-CVD) aims to coordinate national and regional programmes for translational research in the area CVD by implementing one Joint Transnational Call (JTC2016) with EU Co-funding followed by further non-co-funded JTC (2017-2019). Although this consortium will be newly established, a collaboration and alignment of national programmes and activities has already been achieved during the preparation of the ERA-Net Co-fund proposal. This process is supported by CardioScape an EU-funded survey of the European cardiovascular research landscape coordinated by the European Society of Cardiology (ESC). The current ERA-CVD proposal will extend and strengthen the transnational cooperation of the current 23 ministries/institutions/foundations from 18 European, associated and third countries. Furthermore, ERA-CVD plans to cooperate with the ESC and the European Heart Network (EHN). Moreover, the collaboration with European Research Infrastructures, e.g. the ESFRI-initiatives is intended in order to set up an efficient European framework for innovative transnational research on CVD. Also the extension of the consortium and international collaborations are intended.


Geförderte Unternehmen:

Firmenname Förderungssumme
Agence Nationale de la Recherche 802.313 €
Bundesministerium Fuer Forschung Technologie UND Raumfahrt 1.137.675 €
Deutsches Zentrum FUR Luft - UND Raumfahrt e. V. 23.925 €
Fonds de la Recherche Scientifique- FNRS 134.063 €
Fonds Voor Wetenschappelijk Onderzoek-Vlaanderen 134.063 €
Fonds ZUR Förderung DER Wissenschaftlichen Forschung 245.438 €
Fundacao para A Ciencia e A Tecnologia 208.313 €
Instituto de Salud Carlos III 245.438 €
Ministerio da Saude 96.938 €
Ministero Della Salute 616.688 €
Ministerul Educatiei si Cercetarii 171.188 €
Ministrstvo za Izobrazevanje, Znanost in Sport 137.775 €
Ministry OF Health 148.913 €
Narodowe Centrum Badan i Rozwoju 245.438 €
Nasjonalforeningen FOR Folkehelsen 67.650 €
National Science AND Technology Council 0,00 €
Nederlandse Hartstichting 431.063 €
Norges Forskningsrad 245.438 €
SA Eesti Teadusagentuur 96.938 €
Slovenska Akademia Vied 104.363 €
Turkiye Bilimsel VE Teknolojik Arastirma Kurumu 356.813 €
Valsts Izglitibas Attistibas Agentura 171.188 €
Zorgonderzoek Nederland ZON 152.625 €

Quelle: https://cordis.europa.eu/project/id/680969

Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.